Inventor
EGERLAND UTE
DE22 patents
⚠️ This page may combine multiple inventors who share the name “EGERLAND UTE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ELBION AG
7 patentsUS7169787B2Jan 30, 2007
7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same
ELBION AG14 citations92
USRE38624EOct 12, 2004
Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation
ELBION AG20 citations90
US7166637B2Jan 23, 2007
Hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them
ELBION AG12 citations79
US7419987B2Sep 2, 2008
7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
ELBION AG4 citations62
US7211583B2May 1, 2007
7-azaindoles and the use thereof as therapeutic agents
ELBION AG2 citations57
US7067536B2Jun 27, 2006
4-,6- or 7-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agents
ELBION AG2 citations56
US7161009B2Jan 9, 2007
Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
ELBION AG0 citations51
DRESDEN ARZNEIMITTEL
6 patentsUS6251923B1Jun 26, 2001
Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation
DRESDEN ARZNEIMITTEL74 citations96
US6613794B2Sep 2, 2003
Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
DRESDEN ARZNEIMITTEL36 citations95
US6602890B2Aug 5, 2003
Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
DRESDEN ARZNEIMITTEL36 citations95
US6545025B2Apr 8, 2003
Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
DRESDEN ARZNEIMITTEL22 citations92
US6545158B2Apr 8, 2003
Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
DRESDEN ARZNEIMITTEL23 citations92
US6465465B1Oct 15, 2002
Process for the treatment of erectile dysfunction and product therefor
DRESDEN ARZNEIMITTEL4 citations62
JANSSEN PHARMACEUTICALS INC
4 patentsUS9981950B2May 29, 2018
Triazoles as NR2B receptor inhibitors
JANSSEN PHARMACEUTICALS INC17 citations92
US10323021B2Jun 18, 2019
Triazoles as NR2B receptor inhibitors
JANSSEN PHARMACEUTICALS INC13 citations82
US10155727B2Dec 18, 2018
Pyrazoles
JANSSEN PHARMACEUTICALS INC15 citations81
USRE49517EMay 2, 2023
Pyrazoles
JANSSEN PHARMACEUTICALS INC0 citations60